Ka
Kartos Ther
Redwood City CAFounded 201840 employees
Private CapbiotechPrivateHematology
Platform: Myelofibrosis
Market Cap
N/A
All Drugs
3
Clinical Trials
8
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Capilucimab | KAR-2010 | Phase 3 | 4 | TYK2 | Bladder Ca | ||
| KAR-4717 | KAR-4717 | Preclinical | 2 | Nectin-4 | ADPKD | ||
| Elraderotide | KAR-3614 | NDA/BLA | 2 | SMN2 | Endometrial Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)